Chronic hepatitis C treatments, Sovalid and Harvoni passes the first door
Chronic hepatitis C treatments, Sovaldi(sofosbuvir) and complex Harvoni(sofosbuvir, ledipasvir) have passed benefit adequacy evaluations.
This is a great news for the patient group damaged by the Dana Clinic crisis. The two drugs are applied by the benefit once the drug price negotiation is esta...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
